Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function

Author: Tao Li-yang   Liang Yong-ju   Wang Fang   Chen Li-ming   Yan Yan-yan   Dai Chun-ling   Fu Li-wu  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.64, Iss.5, 2009-10, pp. : 961-969

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next